Procter & Gamble Health Limited (BOM: 500126)

Procter & Gamble Health Income Statement

Financials in millions INR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Operating Revenue	11,513	11,513	12,296	11,144	10,087	8,886
Revenue	11,513	11,513	12,296	11,144	10,087	8,886
Revenue Growth (YoY)	-6.37%	-6.37%	10.34%	10.48%	13.52%	-4.10%
Cost of Revenue	3,306	3,306	3,834	3,531	3,245	3,206
Gross Profit	8,207	8,207	8,463	7,614	6,842	5,680
Selling, General & Admin	2,137	2,137	2,811	2,776	2,421	2,460
Other Operating Expenses	2,995	2,995	2,412	2,141	1,943	1,111
Operating Expenses	5,407	5,407	5,504	5,188	4,669	3,789
Operating Income	2,800	2,800	2,959	2,426	2,173	1,892
Interest Expense	-7.2	-7.2	-7.7	-4.2	-8	-
Interest & Investment Income	-	-	143.3	110.7	150.6	572.5
Currency Exchange Gain (Loss)	-	-	3.4	-6.9	-8.9	26.7
Other Non Operating Income (Expenses)	156.3	156.3	30.1	21.2	30.4	-283.96
EBT Excluding Unusual Items	2,950	2,950	3,128	2,546	2,337	2,207
Merger & Restructuring Charges	-14.4	-14.4	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	7.1	-5.4	-4.2	-32.5
Asset Writedown	-201.9	-201.9	7.3	-7.3	-	-
Other Unusual Items	-	-	-	-	-	24.2
Pretax Income	2,733	2,733	3,142	2,534	2,333	2,199
Income Tax Expense	723.4	723.4	847.3	608.5	564.8	539.42
Earnings From Continuing Operations	2,010	2,010	2,295	1,925	1,768	1,659
Net Income	2,010	2,010	2,295	1,925	1,768	1,659
Net Income to Common	2,010	2,010	2,295	1,925	1,768	1,659
Net Income Growth	-12.42%	-12.42%	19.19%	8.89%	6.56%	4.51%
Shares Outstanding (Basic)	17	17	17	17	17	17
Shares Outstanding (Diluted)	17	17	17	17	17	17
Shares Change (YoY)	0.01%	0.01%	-	-	-0.08%	0.08%
EPS (Basic)	121.07	121.07	138.24	115.98	106.51	99.87
EPS (Diluted)	121.07	121.07	138.00	115.98	106.51	99.81
EPS Growth	-12.27%	-12.27%	18.99%	8.89%	6.72%	4.36%
Free Cash Flow	2,066	2,066	1,935	1,316	1,947	1,414
Free Cash Flow Per Share	124.43	124.43	116.58	79.28	117.28	85.11
Dividend Per Share	110.000	110.000	95.000	52.500	40.000	28.000
Dividend Growth	15.79%	15.79%	80.95%	31.25%	42.86%	16.67%
Gross Margin	71.29%	71.29%	68.82%	68.32%	67.83%	63.92%
Operating Margin	24.32%	24.32%	24.06%	21.77%	21.54%	21.29%
Profit Margin	17.46%	17.46%	18.66%	17.28%	17.53%	18.67%
Free Cash Flow Margin	17.94%	17.94%	15.74%	11.81%	19.30%	15.91%
EBITDA	3,074	3,074	3,188	2,648	2,424	2,088
EBITDA Margin	26.70%	26.70%	25.92%	23.76%	24.03%	23.50%
D&A For EBITDA	274	274	229	222.1	251.1	196.33
EBIT	2,800	2,800	2,959	2,426	2,173	1,892
EBIT Margin	24.32%	24.32%	24.06%	21.77%	21.54%	21.29%
Effective Tax Rate	26.47%	26.47%	26.97%	24.02%	24.21%	24.53%
Revenue as Reported	11,669	11,669	12,480	11,276	10,268	9,225
Advertising Expenses	-	-	744.9	1,095	874.1	-

Source: S&P Capital IQ. Standard template. Financial Sources.